

(ShareCast News) - AstraZeneca, the UK's second-biggest drug developer, will this week outline its next big hope in the battle against cancer by unvei...


(ShareCast News) - Exova Group: Goldman Sachs reiterates buy with a 195p target. Grainger: Jefferies retains buy with a 215p target. Thomas Cook: JP ...


(ShareCast News) - Exova expects modest full-year organic growth at constant currency rates and earnings in line with previous guidance, adjusted for ...

